Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul;74(7):661-669.
doi: 10.1055/s-0034-1368589.

Strips of Hope: Accuracy of Home Pregnancy Tests and New Developments

Affiliations

Strips of Hope: Accuracy of Home Pregnancy Tests and New Developments

C Gnoth et al. Geburtshilfe Frauenheilkd. 2014 Jul.

Abstract

The first home pregnancy test was introduced in 1976. Since then, pregnancy tests have become the most common diagnostic assay used at home. Pregnancy tests use antibodies to detect human chorionic gonadotropin (hCG). It is an ideal marker of pregnancy since it rises rapidly and consistently in early pregnancy and can be detected in urine. The most advanced home pregnancy test currently available assesses the level of hCG found in urine and claims to provide women with reliable results within just a few weeks of pregnancy. Today, over 15 different types of home pregnancy test are available to buy over the counter in Germany. Many tests claim to be highly accurate and capable of detecting pregnancy before the next monthly period is due, although claims such as 8 days prior to menstruation are unrealistic. However, users and healthcare professionals should be aware that, although all are labelled as CE, there are currently no standard criteria for testing performance and claims. This review provides an overview of the development of home pregnancy tests and the data on their efficacy together with an analysis of published data on the accuracy of hCG for the detection of early pregnancy and studies on the use of home-based pregnancy tests. Preliminary data on some home pregnancy tests available in Germany are presented which indicate that many results do not match the claims made in the package insert. Healthcare professionals and women should be aware that some of the claims made for home pregnancy tests are inconsistent and that common definitions and testing criteria are urgently needed.

Der erste Urinschwangerschaftstest wurde 1976 vorgestellt und seitdem gehören diese Tests zu den am häufigsten durchgeführten Laboruntersuchungen in der Eigenanwendung. Schwangerschaftstests gehören nach der europäischen Richtlinie 98/79/EG zu den In-vitro-Diagnostika der Medizinprodukte. Sie sind keiner Risikoliste zugeordnet. Anders als in den USA führt weder das Bundesinstitut für Arzneimittel und Medizinprodukte (BMfArM) noch die Zentralstelle der Länder für Gesundheitsschutz bei Arzneimitteln und Medizinprodukten (ZLG) eine Liste geprüfter und zugelassener Schwangerschaftstests. Im vergangenen Jahr war zwischenzeitlich geplant, die hCG-Bestimmung aus dem Urin in der frauenärztlichen Praxis einer externen Qualitätskontrolle zu unterziehen, ohne dass kommerzielle Schwangerschaftstests ihre Genauigkeit und Sensitivität unter Beweis stellen mussten und es bis heute auch keine Standards für eine solche Überprüfung gibt. In Apotheken und Drogeriemärkten in Deutschland sind derzeit über 15 verschiedene Heim-Schwangerschaftstests erhältlich. Viele dieser Schwangerschaftstests behaupten, mit einer hohen Genauigkeit und Empfindlichkeit hCG im Urin festzustellen, oft angeblich bereits einige Tage vor der erwarteten Periodenblutung. Diese Arbeit gibt einen Überblick über die Entwicklung von Urin-Schwangerschaftstests sowie die vorhandenen Daten zur Genauigkeit und Sensitivität der hCG-Messung und informiert über neue Entwicklungen. Es werden erste Daten einer vergleichenden Überprüfung in Deutschland verkaufter Schwangerschaftstests vorgestellt, die zeigen, dass nicht viele den Versprechungen auf ihren Verpackungen genügen. Allen Benutzern von Heim-Schwangerschaftstests müssen die Grenzen dieser Methode und die Anfälligkeit einzelner Tests bekannt sein, um nicht falsche Schlussfolgerungen zu ziehen. In Anbetracht der großen Bedeutung des Ergebnisses eines Schwangerschaftstests für jede einzelne Frau ist auch in Deutschland dringend eine offizielle Prüfung und Zulassung einzelner Tests vor dem Verkauf und später eine Produktüberwachung notwendig.

Keywords: hCG; pregnancy; pregnancy test.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Christian Gnoth: Principle investigator of clinical studies on the performance of fertility monitors, partly supported by SPD (Swiss Precision Diagnostics) Development Company Ltd. Sarah Johnson: Employee of SPD Development Company Limited, a fully owned subsidiary of SPD (Swiss Precision Diagnostics) Development Company Ltd., the manufacturers of “Clearblue pregnancy and fertility tests”.

Figures

Fig. 1
Fig. 1
Daily increase in urinary hCG in early pregnancy in three different studies: The UK Early Pregnancy Study , the UK Standard Care Ultrasound Study and the US Gestational Age Study . The grey area is the 10th to 90th centile band for the US Gestational Age Study .
Fig. 2
Fig. 2
Impact of reference method used to determine pregnancy duration (day of pregnancy calculated from LMP (− 14 days) or from ovulation (LH surge + 1 day) on variability of urinary hCG in early pregnancy normograms by day. Median hCG levels overlay by day; variability was markedly increased when pregnancy duration was calculated from LMP as opposed to ovulation. The grey area is the 10th to 90th centile band for the US Gestational Age Study .
Fig. 3 a
Fig. 3 a
to c Relationship between duration of pregnancy assessed using the Clearblue Digital Pregnancy Test with Conception Indicator and a ultrasound and b LMP; c shows the relationship between pregnancy duration assessed by ultrasound and LMP [27]. CAPT: Clearblue Advanced Pregnancy Test with Conception/Weeks Indicator; CRL: crown rump length; LMP: last menstrual period. A Bland-Altman plot of differences is a method to analyse agreement between two different, but highly correlated methods of measurement. The plot investigates the existence of any systematic difference between the clinical measurements. If the mean difference ± 1.96 SE (standard error, dotted line) of the two methods contains zero then the two methods can be used interchangeably.

Similar articles

Cited by

References

    1. Richtlinie 98/79/EG des Europäischen Parlaments und Rates vom 27. Oktober 1998 über In-vitro-Diagnostika, Anhang III
    1. Öko-Test, Ratgeber Gesundheit und Fitness 8/2008
    1. Birken S, Berger P, Bidart J-M. et al.Preparation and characterisation of new WHO standards for human chorionic gonadotropin and metabolites. Clin Chem. 2003;49:144–154. - PubMed
    1. Bristow A, Berger P, Bidart J. et al.Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin. Clin Chem. 2005;51:177–182. - PubMed
    1. Sturgeon C M, Berger P, Bidart J. et al.Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin. Clin Chem. 2009;55:1484–1491. - PubMed